Novartis AG's Fiscal Year is From January To December.
The item "Ebit-Interest-Coverage" stands at 15.63 as of 09/30/2025, the highest value since 12/31/2022.
As of the end of Novartis AG's third quarter, the item "Ebit Interest Coverage" stands at 15.63. This represents an increase of 4.13 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.69 percent compared to the value the year prior.
The 1 year change in percent is 11.69.
The 3 year change in percent is -47.12.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebit Interest Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebit Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebit Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebit Interest Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebit Interest Coverage | 280,205,508,085.11 |